The Effects of an Exercise Program in Leukemia Patients
Open Access
- 1 June 2009
- journal article
- clinical trial
- Published by SAGE Publications in Integrative Cancer Therapies
- Vol. 8 (2), 130-138
- https://doi.org/10.1177/1534735409334266
Abstract
Purpose. To examine the feasibility of administering an in-hospital exercise program to acute leukemia patients undergoing chemotherapy. A secondary purpose explored the impact of exercise on selected physiological, psychological, and inflammatory markers. Methods. Ten patients, aged 18 to 50 years, diagnosed with acute leukemia or newly relapsed were assessed for body weight, height, body composition (skinfolds), cardiorespiratory endurance (total minutes on bicycle ergometer at 60% heart rate reserve), dynamic muscular endurance (Rocky Mountain Cancer Rehabilitation Institute protocol), fatigue (Revised Piper Fatigue Scale), depression (Center for Epidemiologic Studies Depression scale, National Institute of Mental Health questionnaire), and quality of life (Functional Assessment of Cancer Therapy—General) at baseline (within 3 days of diagnosis) and at the end of induction phase of treatment. Blood draws were taken at baseline, midpoint, and at the end of induction for analyses of inflammatory markers (Linco Luminex assay). Combined aerobic and strength training exercises were administered 3 times per week, twice daily, for 30 minutes. Paired-samples t-tests were used for the analyses of physiological and psychological parameters. One-way repeated measures analysis of variance was used for the analyses of inflammatory markers. Results. Significant improvements in cardiorespiratory endurance ( P = .009, baseline 8.9 ± 8.8 minutes, postexercise intervention 17 ± 14.3 minutes) with significant reductions in total fatigue scores ( P = .009, baseline 4.6 ± 1.7, postexercise intervention 1.8 ± 1.6) and depression scores ( P = .023, baseline 19 ± 11.5, postexercise intervention 12 ± 8.2) were observed. Marginally significant decrease in interleukin-6 (IL-6; P = .059) with no significant changes in IL-10 ( P = .223) or interferon-γ ( P = .882) were observed. Conclusion. Administration of exercise to acute leukemia patients undergoing treatment is feasible. The exercise protocol used increased cardiovascular endurance, reduced fatigue and depression scores, and maintained quality of life. Although no significant change in inflammation was observed, a trend demonstrating a reduction in IL-6 and an increase in IL-10 warrants further investigation.Keywords
This publication has 26 references indexed in Scilit:
- Influence of Pre- and Postdiagnosis Physical Activity on Mortality in Breast Cancer Survivors: The Health, Eating, Activity, and Lifestyle StudyJournal of Clinical Oncology, 2008
- Effects of Aerobic and Resistance Exercise in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Multicenter Randomized Controlled TrialJournal of Clinical Oncology, 2007
- Main Outcomes of the FRESH START Trial: A Sequentially Tailored, Diet and Exercise Mailed Print Intervention Among Breast and Prostate Cancer SurvivorsJournal of Clinical Oncology, 2007
- Body composition, exercise and energy expenditure in survivors of acute lymphoblastic leukaemiaPediatric Blood & Cancer, 2007
- The anti-inflammatory effect of exerciseJournal of Applied Physiology, 2005
- Randomized controlled trial of exercise and blood immune function in postmenopausal breast cancer survivorsJournal of Applied Physiology, 2005
- Review of Exercise Intervention Studies in Cancer PatientsJournal of Clinical Oncology, 2005
- Effects of endurance training on the physical performance of patients with hematological malignancies during chemotherapySupportive Care in Cancer, 2003
- Randomized Controlled Trial of Exercise Training in Postmenopausal Breast Cancer Survivors: Cardiopulmonary and Quality of Life OutcomesJournal of Clinical Oncology, 2003
- A pilot study of group exercise training (GET) for women with primary breast cancer: feasibility and health benefitsPsycho‐Oncology, 2002